US 12042510
Modulators of IRF4 expression
granted A61KA61K31/7088A61K31/7115
Quick answer
US patent 12042510 (Modulators of IRF4 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7088, A61K31/7115, A61K31/712, A61K31/7125